IGHG3 and myalgic encephalomeyelitis/chronic fatigue syndrome: (2023) identified significantly elevated levels of IgG3 and IgG4 subclasses in long COVID patients with concomitant Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), suggesting a role in the immunopathology of long COVID (238).